v3.26.1
Revenue (Tables)
 3 Months Ended
Mar. 31, 2026
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
Our disaggregated revenues were as follows (in thousands):
Three Months Ended
March 31,
20262025
Royalties$240,681 $168,192 
Product sales, net
Proprietary product sales
41,873 36,341 
Bulk rHuPH20 sales
73,497 27,025 
Device partnered product sales
15,054 14,675 
Total product sales, net130,424 78,041 
Revenues under collaborative agreements
Upfront license and target nomination fees
— 220 
Sales-based milestones
— 15,000 
Device licensing and development revenue
5,603 3,408 
Total revenues under collaborative agreements5,603 18,628 
Total revenues$376,708 $264,861 
Schedule of Accounts Receivable, Other Contract Assets and Contract Liabilities
Accounts receivable, net, other contract assets and deferred revenues (contract liabilities) from contracts with customers, including partners, consisted of the following (in thousands):
March 31, 2026December 31, 2025
Accounts receivable, net$457,989 $426,273 
Other contract assets— 15,000 
Deferred revenues32,945 35,482